Proposed Data Collection Submitted for Public Comment and Recommendations, 66311-66313 [2021-25449]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1254; Docket No. CDC–2021–
0121]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Communities Organized to
Prevent Arboviruses: Assessment of
Knowledge, Attitudes, and Vector
Control Practices and Sero-Prevalence
and Incidence of Arboviral Infection in
Ponce, Puerto Rico (COPA Study). The
purpose of this study is to measure the
incidence of arboviral infections in 38
communities in southern Puerto Rico.
DATES: CDC must receive written
comments on or before January 21,
2022.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0121 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
jspears on DSK121TN23PROD with NOTICES1
ADDRESSES:
VerDate Sep<11>2014
19:31 Nov 19, 2021
Jkt 256001
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Communities Organized to Prevent
Arboviruses: Assessment of Knowledge,
Attitudes, and Vector Control Practices
and Sero-Prevalence and Incidence of
Arboviral Infection in Ponce, Puerto
Rico (COPA Study)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The four viruses that cause dengue are
transmitted by Aedes species
mosquitoes and were introduced to the
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
66311
Americas over the past several hundred
years where they have since become
endemic. Puerto Rico, a Caribbean
island and U.S. commonwealth, has the
highest burden of dengue virus in the
U.S., and recent years have seen the
emergence of two epidemic arthropodborne viruses (arboviruses) also
transmitted by Aedes mosquitoes.
Chikungunya virus was introduced into
the Caribbean in late 2013 and caused
large epidemics of fever with severe
joint pain throughout the Caribbean and
Americas in 2014. Zika virus, the first
arbovirus that can also be transmitted
through sexual contact, was first
detected in the Americas in 2014 and
has been associated with devastating
birth defects and Guillain-Barre
syndrome. Yellow fever virus has
recently caused large outbreaks in
Brazil, and there is risk of importation
to Puerto Rico and other counties in the
Americas.
The public health response to the
spread of these arboviruses throughout
the tropics, where their mosquito
vectors thrive, has been hampered by a
lack of sustainable and effective
interventions to prevent infection with
any of these arboviruses at the
community level. Moreover, the rapid
speed with which new arboviruses
spread does not often provide the time
needed to plan and implement
community-level interventions to
decrease disease transmission. Although
several candidate vaccines for
chikungunya and Zika viruses are
currently in clinical development, none
are yet available. A dengue vaccine was
recently recommended for children 9–
16 years old with previous dengue
infection and living in dengue-endemic
parts of the United States. However, this
will only benefit a small proportion of
the population at risk for dengue
infection.
The purpose of the Communities
Organized to Prevent Arboviruses
(COPA) project is to measure the
incidence of arboviral infections and
assess suitability, acceptability, and
impact of community-level mosquito
control interventions in 38 communities
in southern Puerto Rico. The study
investigators have prior experience
working in these communities;
however, there is minimal available
information regarding the prevalence or
incidence of infection with tropical
arboviruses, density of Ae. aegypti
mosquitos, or community members’
knowledge, attitudes, and practices
E:\FR\FM\22NON1.SGM
22NON1
jspears on DSK121TN23PROD with NOTICES1
66312
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
regarding behaviors intended to avoid
mosquitos. Such information will be
needed to inform decision-making
regarding the location, design, and
content of mosquito control
interventions to be implemented, as
well as to evaluate their effectiveness in
reducing the arbovirus burden.
Additionally, the COPA project can act
as a research platform to assess
acceptability of arbovirus vaccines and
other individual level prevention
measures in Puerto Rico and provide
community-level data on emerging
diseases, including novel coronavirus
2019 (COVID–19).
CDC plans to collect demographic
information (e.g., age, sex, duration of
time residing in Puerto Rico), travel
history, and information on recent
illnesses from all participants via
household (and individual)
questionnaires. Parents or guardians
will serve as proxy respondents for
children aged <7 years. The
questionnaires will be administered
after written consent and written or
verbal assent (for minors) from those
present in the household at the time of
the visit. GPS coordinates will also be
collected for each household visited to
later assess for potential clustering of
arboviral infections within
communities. We will ask participants if
they have been ill with arbovirus- or
COVID–19-like illness (i.e., fever, rash,
fever, cough, sore throat, difficulty
breathing, diarrhea, body pain, or loss of
taste/smell in the last week) in the past
week and year. If so, we will collect
details on the symptoms experienced
during their illness. The questionnaires
will be administered to Ponce residents
from the 38 communities in Ponce,
Puerto Rico. Being a resident is defined
by having slept in the house for at least
four of the past seven nights. At the time
of the questionnaire administration, ∼15
mL of blood will be collected to conduct
serological testing of arboviruses for a
sero-survey. If the participant has
COVID–19-like symptoms, an anterior
nasal swab will also be collected.
The questionnaire section will vary
depending on the age of each
participant. The Household
questionnaire will be administered to
one household representative in each
home with one or more COPA
participants. This representative should
be 21 years or older or an emancipated
minor. This information is key to
understand the household composition,
characteristics, and use of chemical
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
insecticides and other preventive
practices. If all eligible household
members are unemancipated minors, a
household member over the age of 50
may act as household representative and
complete this section of the survey only.
The Individual questionnaire will be
administered to all participants to
collect individual-level sociodemographic information. This
questionnaire will collect information
on past illnesses and health seeking
behaviors, identify the main healthcare
facilities used in the area, and estimate
costs associated with acute febrile
illness. Questions related to COVID–19
vaccine uptake, illness, and diagnosis
are also included to describe and
estimate the number of previous SARS–
CoV–2 infections and evaluate the
success of ongoing COVID–19
vaccination efforts in these
communities.
The Mobility questionnaire will be
administered to all participants to assess
general individual-level mobility
patterns, including time spent in and
outside of the home each week. We will
ask participants about the location and
characteristics of places where they
spend more than five hours per week to
assess potential arboviral exposures
outside of the home.
The assessment of Knowledge,
Attitudes, and Practices (KAP)
questionnaire will be administered to
participants 14–50 years old to collect
information on knowledge, perceptions
of risk and prevention measures, and
past experience with dengue and
COVID–19. Data will be used to
understand how community members
view arboviral diseases and COVID–19,
and how these perceptions relate to
experience and willingness to adopt
individual and community-level
prevention measures. Questions related
to general perceptions and confidence
in vaccines will be asked to see how
these relate to intentions to vaccinate
against dengue and COVID–19.
A Vector Control Tools questionnaire
will be administered to all household
representatives to evaluate knowledge
and acceptability of several mosquito
control methods. This information will
be shared with local governments and
vector control agencies to inform
selection and implementation of
potential mosquito control interventions
in the region.
An Acute Illness Surveillance (AIS)
project component is being
implemented to better identify and
assess the incidence of arboviral disease
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
and COVID–19 among COPA
participants. This additional weekly
activity will use an automated textmessaging system to ask COPA
household representatives and other
household adults who consent to
receive text messages if any COPA
participants in the household have
experienced fever or other COVID-like
symptoms in the past seven days.
Project staff will contact households in
which one or more participants reported
symptoms to schedule an appointment
to collect samples for arbovirus and
SARS–CoV–2 molecular testing and to
administer a AIS questionnaire about
symptoms, exposure and health seeking
behaviors. From previous febrile
surveillance studies, we expect
approximately 40% of household adults
will respond to text messages each week
and 10% of COPA participants will
report acute symptoms and agree to a
sample collection visit each year.
Participants with a positive SARS–
CoV–2 molecular test will be contacted
by phone 2–4 weeks later for a COVID–
19 Case Follow-up questionnaire on
symptoms, health care seeking,
potential exposures, and outcomes of
SARS–CoV–2 infection. We are
expecting that 20% of participant that
report symptoms will have a positive
COVID–19 result and respond to this
follow-up questionnaire.
The central COPA questionnaires
(Household, Individual, KAP, Mobility,
Vector Control) will be repeated among
approximately 3,800 participants every
12 months, up to a period of five years.
The AIS and COVID–19 follow-up
components will be renewed and
modified annually as applicable
according to research and funding
priorities. This project will allow us to
better understand the risk, perceptions,
and burden of arboviral infections and
COVID–19 and evaluate a communitybased approach for vector control in 38
communities in Ponce, Puerto Rico. The
information obtained will inform
decision making regarding the location,
design, content, and evaluation of future
mosquito control interventions
implemented in Puerto Rico. Data on
incidence and perception of COVID–19
disease will also be used to inform local
control programs and fill the current
knowledge gaps.
There is no burden on respondents
other than the time needed to
participate. Estimated annual burden is
4,309 hours.
E:\FR\FM\22NON1.SGM
22NON1
66313
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
(in hours)
Form name
Ponce residents from the 38 selected communities 21
years and older or emancipated minor.
Ponce residents from the 38 selected communities 1–50
years old.
Ponce residents from the 38 selected communities 1–50
years old.
Ponce residents from the 38 selected communities 14–
50 years old.
Ponce residents from the 38 selected communities 1–50
years old.
Ponce residents from the 38 selected communities 21
years and older.
Ponce residents from the 38 selected communities 21
years and older.
Ponce residents from the 38 selected communities with
inclusion criteria.
Ponce residents from the 38 selected communities with
inclusion criteria that tested positive for SAR–CoV–2.
Household Representative questionnaire.
Individual questionnaire .....................
2,700
1
10/60
450
3,800
1
20/60
1,267
Specimen Collection ..........................
3,800
1
5/60
317
Knowledge, Attitudes, and Practices
questionnaire.
Mobility ...............................................
3,090
1
15/60
773
3,800
1
10/60
633
Vector Control ....................................
2,500
1
10/60
417
AIS text message ...............................
1,000
52
0.5/60
433
AIS questionnaire ...............................
380
1
8/60
51
COVID–19 case follow-up questionnaire.
75
1
6/60
8
Total ...........................................................................
............................................................
........................
........................
........................
4,309
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–25449 Filed 11–19–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10515]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
January 21, 2022.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: _, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10515 Payment Collections
Operations Contingency Plan
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Payment
Collections Operations Contingency
Plan; Use: Under sections 1401, 1411,
and 1412 of the Patient Protection and
Affordable Care Act (PPACA) and 45
CFR part 155 subpart D, an Exchange
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66311-66313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25449]
[[Page 66311]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1254; Docket No. CDC-2021-0121]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Communities Organized to Prevent
Arboviruses: Assessment of Knowledge, Attitudes, and Vector Control
Practices and Sero-Prevalence and Incidence of Arboviral Infection in
Ponce, Puerto Rico (COPA Study). The purpose of this study is to
measure the incidence of arboviral infections in 38 communities in
southern Puerto Rico.
DATES: CDC must receive written comments on or before January 21, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0121 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Communities Organized to Prevent Arboviruses: Assessment of
Knowledge, Attitudes, and Vector Control Practices and Sero-Prevalence
and Incidence of Arboviral Infection in Ponce, Puerto Rico (COPA
Study)--Revision--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The four viruses that cause dengue are transmitted by Aedes species
mosquitoes and were introduced to the Americas over the past several
hundred years where they have since become endemic. Puerto Rico, a
Caribbean island and U.S. commonwealth, has the highest burden of
dengue virus in the U.S., and recent years have seen the emergence of
two epidemic arthropod-borne viruses (arboviruses) also transmitted by
Aedes mosquitoes. Chikungunya virus was introduced into the Caribbean
in late 2013 and caused large epidemics of fever with severe joint pain
throughout the Caribbean and Americas in 2014. Zika virus, the first
arbovirus that can also be transmitted through sexual contact, was
first detected in the Americas in 2014 and has been associated with
devastating birth defects and Guillain-Barre syndrome. Yellow fever
virus has recently caused large outbreaks in Brazil, and there is risk
of importation to Puerto Rico and other counties in the Americas.
The public health response to the spread of these arboviruses
throughout the tropics, where their mosquito vectors thrive, has been
hampered by a lack of sustainable and effective interventions to
prevent infection with any of these arboviruses at the community level.
Moreover, the rapid speed with which new arboviruses spread does not
often provide the time needed to plan and implement community-level
interventions to decrease disease transmission. Although several
candidate vaccines for chikungunya and Zika viruses are currently in
clinical development, none are yet available. A dengue vaccine was
recently recommended for children 9-16 years old with previous dengue
infection and living in dengue-endemic parts of the United States.
However, this will only benefit a small proportion of the population at
risk for dengue infection.
The purpose of the Communities Organized to Prevent Arboviruses
(COPA) project is to measure the incidence of arboviral infections and
assess suitability, acceptability, and impact of community-level
mosquito control interventions in 38 communities in southern Puerto
Rico. The study investigators have prior experience working in these
communities; however, there is minimal available information regarding
the prevalence or incidence of infection with tropical arboviruses,
density of Ae. aegypti mosquitos, or community members' knowledge,
attitudes, and practices
[[Page 66312]]
regarding behaviors intended to avoid mosquitos. Such information will
be needed to inform decision-making regarding the location, design, and
content of mosquito control interventions to be implemented, as well as
to evaluate their effectiveness in reducing the arbovirus burden.
Additionally, the COPA project can act as a research platform to assess
acceptability of arbovirus vaccines and other individual level
prevention measures in Puerto Rico and provide community-level data on
emerging diseases, including novel coronavirus 2019 (COVID-19).
CDC plans to collect demographic information (e.g., age, sex,
duration of time residing in Puerto Rico), travel history, and
information on recent illnesses from all participants via household
(and individual) questionnaires. Parents or guardians will serve as
proxy respondents for children aged <7 years. The questionnaires will
be administered after written consent and written or verbal assent (for
minors) from those present in the household at the time of the visit.
GPS coordinates will also be collected for each household visited to
later assess for potential clustering of arboviral infections within
communities. We will ask participants if they have been ill with
arbovirus- or COVID-19-like illness (i.e., fever, rash, fever, cough,
sore throat, difficulty breathing, diarrhea, body pain, or loss of
taste/smell in the last week) in the past week and year. If so, we will
collect details on the symptoms experienced during their illness. The
questionnaires will be administered to Ponce residents from the 38
communities in Ponce, Puerto Rico. Being a resident is defined by
having slept in the house for at least four of the past seven nights.
At the time of the questionnaire administration, ~15 mL of blood will
be collected to conduct serological testing of arboviruses for a sero-
survey. If the participant has COVID-19-like symptoms, an anterior
nasal swab will also be collected.
The questionnaire section will vary depending on the age of each
participant. The Household questionnaire will be administered to one
household representative in each home with one or more COPA
participants. This representative should be 21 years or older or an
emancipated minor. This information is key to understand the household
composition, characteristics, and use of chemical insecticides and
other preventive practices. If all eligible household members are
unemancipated minors, a household member over the age of 50 may act as
household representative and complete this section of the survey only.
The Individual questionnaire will be administered to all
participants to collect individual-level socio-demographic information.
This questionnaire will collect information on past illnesses and
health seeking behaviors, identify the main healthcare facilities used
in the area, and estimate costs associated with acute febrile illness.
Questions related to COVID-19 vaccine uptake, illness, and diagnosis
are also included to describe and estimate the number of previous SARS-
CoV-2 infections and evaluate the success of ongoing COVID-19
vaccination efforts in these communities.
The Mobility questionnaire will be administered to all participants
to assess general individual-level mobility patterns, including time
spent in and outside of the home each week. We will ask participants
about the location and characteristics of places where they spend more
than five hours per week to assess potential arboviral exposures
outside of the home.
The assessment of Knowledge, Attitudes, and Practices (KAP)
questionnaire will be administered to participants 14-50 years old to
collect information on knowledge, perceptions of risk and prevention
measures, and past experience with dengue and COVID-19. Data will be
used to understand how community members view arboviral diseases and
COVID-19, and how these perceptions relate to experience and
willingness to adopt individual and community-level prevention
measures. Questions related to general perceptions and confidence in
vaccines will be asked to see how these relate to intentions to
vaccinate against dengue and COVID-19.
A Vector Control Tools questionnaire will be administered to all
household representatives to evaluate knowledge and acceptability of
several mosquito control methods. This information will be shared with
local governments and vector control agencies to inform selection and
implementation of potential mosquito control interventions in the
region.
An Acute Illness Surveillance (AIS) project component is being
implemented to better identify and assess the incidence of arboviral
disease and COVID-19 among COPA participants. This additional weekly
activity will use an automated text-messaging system to ask COPA
household representatives and other household adults who consent to
receive text messages if any COPA participants in the household have
experienced fever or other COVID-like symptoms in the past seven days.
Project staff will contact households in which one or more participants
reported symptoms to schedule an appointment to collect samples for
arbovirus and SARS-CoV-2 molecular testing and to administer a AIS
questionnaire about symptoms, exposure and health seeking behaviors.
From previous febrile surveillance studies, we expect approximately 40%
of household adults will respond to text messages each week and 10% of
COPA participants will report acute symptoms and agree to a sample
collection visit each year.
Participants with a positive SARS-CoV-2 molecular test will be
contacted by phone 2-4 weeks later for a COVID-19 Case Follow-up
questionnaire on symptoms, health care seeking, potential exposures,
and outcomes of SARS-CoV-2 infection. We are expecting that 20% of
participant that report symptoms will have a positive COVID-19 result
and respond to this follow-up questionnaire.
The central COPA questionnaires (Household, Individual, KAP,
Mobility, Vector Control) will be repeated among approximately 3,800
participants every 12 months, up to a period of five years. The AIS and
COVID-19 follow-up components will be renewed and modified annually as
applicable according to research and funding priorities. This project
will allow us to better understand the risk, perceptions, and burden of
arboviral infections and COVID-19 and evaluate a community-based
approach for vector control in 38 communities in Ponce, Puerto Rico.
The information obtained will inform decision making regarding the
location, design, content, and evaluation of future mosquito control
interventions implemented in Puerto Rico. Data on incidence and
perception of COVID-19 disease will also be used to inform local
control programs and fill the current knowledge gaps.
There is no burden on respondents other than the time needed to
participate. Estimated annual burden is 4,309 hours.
[[Page 66313]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Ponce residents from the 38 Household 2,700 1 10/60 450
selected communities 21 years Representative
and older or emancipated questionnaire.
minor.
Ponce residents from the 38 Individual 3,800 1 20/60 1,267
selected communities 1-50 questionnaire.
years old.
Ponce residents from the 38 Specimen 3,800 1 5/60 317
selected communities 1-50 Collection.
years old.
Ponce residents from the 38 Knowledge, 3,090 1 15/60 773
selected communities 14-50 Attitudes, and
years old. Practices
questionnaire.
Ponce residents from the 38 Mobility........ 3,800 1 10/60 633
selected communities 1-50
years old.
Ponce residents from the 38 Vector Control.. 2,500 1 10/60 417
selected communities 21 years
and older.
Ponce residents from the 38 AIS text message 1,000 52 0.5/60 433
selected communities 21 years
and older.
Ponce residents from the 38 AIS 380 1 8/60 51
selected communities with questionnaire.
inclusion criteria.
Ponce residents from the 38 COVID-19 case 75 1 6/60 8
selected communities with follow-up
inclusion criteria that questionnaire.
tested positive for SAR-CoV-2.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,309
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-25449 Filed 11-19-21; 8:45 am]
BILLING CODE 4163-18-P
